Bio-Rad Laboratories, Inc.BIONYSE
LOADING
|||
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-208.83%
↓ 3420% below average
Average (39q)
6.29%
Historical baseline
Range
High:838.30%
Low:-1799.14%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -208.83% |
| Q2 2025 | 409.61% |
| Q1 2025 | 108.96% |
| Q4 2024 | -209.41% |
| Q3 2024 | 130.65% |
| Q2 2024 | -666.57% |
| Q1 2024 | 10.78% |
| Q4 2023 | 232.88% |
| Q3 2023 | 109.22% |
| Q2 2023 | -1799.14% |
| Q1 2023 | -91.65% |
| Q4 2022 | 604.34% |
| Q3 2022 | 82.23% |
| Q2 2022 | 72.36% |
| Q1 2022 | -114.07% |
| Q4 2021 | -139.92% |
| Q3 2021 | 329.01% |
| Q2 2021 | -6.29% |
| Q1 2021 | 16.49% |
| Q4 2020 | -36.42% |
| Q3 2020 | 35.75% |
| Q2 2020 | 41.88% |
| Q1 2020 | 24.16% |
| Q4 2019 | 313.13% |
| Q3 2019 | -143.23% |
| Q2 2019 | -30.83% |
| Q1 2019 | 204.12% |
| Q4 2018 | -409.09% |
| Q3 2018 | 0.33% |
| Q2 2018 | -59.23% |
| Q1 2018 | 838.30% |
| Q4 2017 | 217.57% |
| Q3 2017 | 335.29% |
| Q2 2017 | -59.52% |
| Q1 2017 | 160.00% |
| Q4 2016 | -211.11% |
| Q3 2016 | 3.28% |
| Q2 2016 | 45.24% |
| Q1 2016 | -75.15% |
| Q4 2015 | 186.44% |